Generic medicines are those where patent protection has expired, and which may be
produced by manufacturers other than the innovator company. Use of generic medicines …

All European countries are facing growing pharmaceutical expenditure, particularly in public
expenditure [3] given that Europe has a comparatively higher coverage of publicly funded …

Policy Points: Our study indicates that there are opportunities for cost savings in generic
drug markets in Europe and the United States. Regulators should make it easier for generic …

The WHO European Region has seen remarkable health gains in populations that have
experienced progressive improvements in the conditions in which people are born, grow …

It is a continual challenge trying to improve the quality of prescribing while concurrently
trying to address increasing pharmaceutical development, utilization and expenditure …

Generic medicines have the same efficacy and safety as originators at lower prices;
however, there are concerns with their utilization in Nigeria. Objective was to evaluate …

Demand-side policies to encourage the use of generic medicines are important to increase
their use. A plethora of different demand-side policies has already been initiated by …

The economic downfall in Lebanon and the destruction of the Beirut Port have had a
crippling effect on all players in the health sector, including hospitals, healthcare providers …

In polygynous roe deer Capreolus capreolus, males are only slightly heavier than females
and the overall sex ratio at birth is close to unity. We studied offspring sex ratio and litter size …

This study provides an overview of policy measures targeting pharmaceutical expenditure in
Europe and analyses their impact on originator pharmaceutical prices. Panel data methods …